Skip to content

Annals of Clinical and Analytical Medicine

E-ISSN: 2667-663X · Monthly · English

Relationship between metabolic syndrome and prostate cancer

Metabolic syndrome and prostate cancer

Abstract

Aim Metabolic syndrome has gained increased attention in the last century after researchers identified its important role in cardiovascular mortality and morbidity in developed countries. Despite limited research into the relationship between metabolic syndrome and prostate cancer (PCa), the precise relationship has not been elucidated due to lack of research into the specific factors associated with PCa. To fill this research gap, we evaluated the incidence of PCa in patients with metabolic syndrome and the relationship between metabolic syndrome and the parameters of PCa.Methods We retrospectively evaluated the biochemical analyses of the serum parameters and pathological reports of 102 PCa patients diagnosed by transrectal ultrasound. After determining the incidence of metabolic syndrome in patients with PCa, we divided the patients into two groups, those with and without a diagnosis of metabolic syndrome. We then compared the serum PSA level, age, total prostate volume, Gleason score, triglyceride (TG) level, high-density lipoprotein cholesterol level (HDL-C), blood pressure, and fasting glucose level of the two groups.Results We included 102 patients with a diagnosis of prostate cancer in the present study. Among the 102 patients, 18 (17.6%) were diagnosed with metabolic syndrome. While the PSA levels of the PCa patients were found to be significantly lower in those with metabolic syndrome compared to those without metabolic syndrome (P=0.04), no difference was found between the groups regarding the other components of
PCa (P>0.05).ConclusionSerum PSA level was found to be significantly lower in those with metabolic syndrome. This result leads us to consider whether prostate biopsy should be performed in patients with metabolic syndrome who have lower PSA levels than the levels currently specified for biopsy. Further research into the parameters of PCa needs to be conducted to confirm our findings.

Keywords

ınsulin resistancemetabolic syndrome Xprostate cancerprostate specific antigentransrectal ultrasound

Additional Information

Publisher’s Note
Bayrakol MP remains neutral with regard to jurisdictional and institutional claims.

Rights and Permissions

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of the license, visit https://creativecommons.org/licenses/by-nc/4.0/

About This Article

How to Cite This Article

Serkan Bas, Mustafa Yuksel, Serdar Yılmaz, Soner Yalcınkaya, Ekrem Islamoglu, Husnu Tokgoz, Tumay Ipekci, Murat Savas. Relationship between metabolic syndrome and prostate cancer. J Clin Anal Med 2016;7(4):520-523. doi:10.4328/JCAM.4445

Publication History

Received:
29.02.2016
Accepted:
16.03.2016
Published Online:
01.07.2016
Printed:
01.07.2016